- Home
- TLS vs FDMT Comparison
TLS vs FDMT Comparison
Compare TLS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLS | FDMT |
|---|---|---|
| Founded | 1969 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.6M | 455.4M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TLS | FDMT |
|---|---|---|
| Price | $5.63 | $7.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $7.75 | ★ $30.33 |
| AVG Volume (30 Days) | 914.1K | ★ 1.2M |
| Earning Date | 11-10-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $144,400,000.00 | $120,000.00 |
| Revenue This Year | $52.26 | $21,181.08 |
| Revenue Next Year | $19.65 | $162.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 17.44 | ★ 605.88 |
| 52 Week Low | $1.83 | $2.24 |
| 52 Week High | $8.36 | $12.34 |
Technical Indicators
Market Signals| Indicator | TLS | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 55.25 | 42.43 |
| Support Level | $5.50 | $7.13 |
| Resistance Level | $5.88 | $8.06 |
| Average True Range (ATR) | 0.22 | 0.51 |
| MACD | 0.10 | 0.13 |
| Stochastic Oscillator | 77.20 | 37.84 |
Price Performance
Historical ComparisonAbout TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.